Pharmaceuticals & Biotech Dutch Community
Our community narratives are driven by numbers and valuation.
Pharmaceuticals & Biotech Dutch Investing Ideas
APDS Prevalence Uncertainty And Pipeline Delays Will Test Long-Term Rare Disease Thesis
Catalysts About Pharming Group Pharming Group focuses on rare disease treatments, with commercial therapies for hereditary angioedema and APDS and a late stage program in primary mitochondrial disease. What are the underlying business or industry changes driving this perspective?Read more
Cell Therapy Exit And Single Late Stage Asset Will Drive Weaker Long Term Earnings
Catalysts About Galapagos Galapagos is a biotech company that is repositioning itself as a lean, cash rich platform focused on external business development and a limited internal pipeline. What are the underlying business or industry changes driving this perspective?Read more
Clinically Derisked Oncology Assets And Gilead Partnership Will Drive Long Term Earnings Potential
Catalysts About Galapagos Galapagos is repositioning as a capital rich, business development driven biotech company focused on acquiring and advancing clinically derisked assets. What are the underlying business or industry changes driving this perspective?Read more
Rare Disease Expansion Will Drive Durable Long Term Upside In This Biotech
Catalysts About Pharming Group Pharming Group is a commercial-stage biotech company focused on developing and marketing innovative therapies for rare and ultra-rare diseases. What are the underlying business or industry changes driving this perspective?Read more
Rare Disease Therapies And Expanded Diagnoses Will Drive Strong Long Term Upside
Catalysts About Pharming Group Pharming Group is a rare disease biotechnology company focused on developing and commercializing innovative therapies for patients with significant unmet medical needs. What are the underlying business or industry changes driving this perspective?Read more
Cell Therapy Wind Down And Cash Reserves Will Drive A Leaner, Stronger Biotech Future
Catalysts About Galapagos Galapagos is a biotechnology company focused on using its substantial capital base and deal-making expertise to build a differentiated, late stage therapeutic pipeline. What are the underlying business or industry changes driving this perspective?Read more
